Determinants of folic acid intake during preconception and in early pregnancy by mothers in Ibadan, Nigeria
Taiwo Akeem Lawal, Amos Olufemi Adeleye
The Pan African Medical Journal. 2014;19:113. doi:10.11604/pamj.2014.19.113.4448

Create an account  |  Sign in
African Case Studies Case studies in Public health
"Better health through knowledge sharing and information dissemination "

Research

Determinants of folic acid intake during preconception and in early pregnancy by mothers in Ibadan, Nigeria

Cite this: The Pan African Medical Journal. 2014;19:113. doi:10.11604/pamj.2014.19.113.4448

Received: 24/04/2014 - Accepted: 27/08/2014 - Published: 01/10/2014

Key words: Periconceptional, folic acid, neural tube defects, prevention, determinants

© Taiwo Akeem Lawal et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Available online at: http://www.panafrican-med-journal.com/content/article/19/113/full

Corresponding author: Taiwo Akeem Lawal, Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria (taiwo.lawal@hotmail.com)


Determinants of folic acid intake during preconception and in early pregnancy by mothers in Ibadan, Nigeria

 

Taiwo Akeem Lawal1,&, Amos Olufemi Adeleye2

 

1Division of Paediatric Surgery, Department of Surgery, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria, 2Division of Neurological Surgery, Department of Surgery, College of Medicine, University of Ibadan, and Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria

 

 

&Corresponding author
Taiwo Akeem Lawal, Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria

 

 

Abstract

Introduction: In order to identify targets for primary preventive strategies, we explored possible predictors of periconceptional folic acid (pFA) intake in a Nigerian population of reproductively active women.

 

Methods: A cross sectional study of mothers attending immunization clinics at two hospitals was conducted between May and November 2012. Information obtained included sociodemographic and obstetric details and periconceptional usage of FA. Independent variables were analysed as predictors of pFA intake using chi-square statistical test and multinomial logistic regression.

 

Results: The study involved 602 mothers aged 17 to 42 years; 23% had a university degree and 66% were in the working class. Preconceptional usage was proven in only 15 (2.5%). Periconceptional usage was more likely among professionals (X2 = 41.194, p < 0.001), those with university degree (X2 = 53.089, p < 0.001),are primigravid (X2 = 18.415, p < 0.001) and early antenatal clinic attendees (X2 = 355.9, p < 0.001). Women were less likely to know that FA could prevent birth defects if in the working class (1.7% vs. 11.1%, X2 = 25.593, p < 0.001), less educated (0.5 vs. 10.9%, X2 = 38.083, p < 0.001) or booked late for antenatal care (2.0 vs. 5.9%, X2 = 5.767, p = 0.016). The determinants of late commencement of FA were low social class (OR = 4.29, 95% CI: 1.59, 11.31), lack of university education (OR = 4.58, 95% CI: 3.06, 6.87) and late booking (OR = 104.27, 95% CI: 53.09, 204.76).

 

Conclusion: In this population of reproductively active women, pFA intake and knowledge of its health benefits are poor amongst mothers - in working class, with limited education, and who present late for antenatal care.

 

 

Introduction

The incidence of neural tube defects (NTDs) in developing countries has been reported to be up to four-fold higher than in developed ones [1, 2]. The life-long medical and socio-economic consequences of NTDs in affected children are equally known to be worse in low-resource settings. Folic acid (FA) taken by women at least four weeks prior to conception and throughout the first trimester of pregnancy, or periconceptional FA intake, has been associated with up to 80% reduction in the incidence of NTDs [3, 4]. Early exposure in pregnancy to FA has also been found beneficial in the prevention of some other reproductive mishaps like congenital heart diseases, cleft lip and palate, limb defects and anorectal malformations [5, 6]. In developing countries, the absence of pre-conceptional counselling coupled with sub-optimal antenatal care services is a barrier to reducing the incidence of NTDs [7]. In order to identify targets for primary preventive strategies, we aimed to ascertain factors associated with periconceptional intake of FA as well as the level of the knowledge of its role in the prevention of birth defects in a selected Nigerian population of reproductively active women. It was also hoped that this would give insights into the possible predictors of late commencement of FA by this study population.

 

 

Methods

A descriptive cross sectional study of mothers attending postnatal immunization clinics at two hospitals in Ibadan, Nigeria, was conducted between May and November 2012. The first health facility is a general hospital administered by the state government, which caters for citizens majorly from the low socioeconomic groups in the state capital. The second one is a tertiary hospital operated by the federal government with its clientele from all strata of the society. The two hospitals, with the highest delivery rates in the state, were selected to have a sample containing mothers from the different strata of the population. Following ethical approval from the Joint University of Ibadan/University College Hospital Ethical Review Committee, structured, pretested, interviewer-administered questionnaires were used to obtain information from 602 consenting mothers consecutively selected at the two hospitals using simple random sampling technique. A table of random numbers was used and a list of mothers who signed the attendance list in the morning of the clinic used to generate the sampling frame. A minimum sample size of 220 women from each hospital, i.e. total of 440, was estimated to be adequate; assuming the proportion of women of reproductive age group who used FA periconception to be 17% [8] using a precision (d) of 5% and 95% confidence interval. Information obtained with the questionnaire included sociodemographic details of age, occupation, marital status and highest completed level of education; maternal obstetric characteristics such as parity, gravidity, details of antenatal care and time of registration; and use of FA. The women were asked if they ever used FA prior to conception, within the first trimester of pregnancy or at any other time during pregnancy. The time of commencement of FA intake, the doses, the reason for using the FA and information concerning who prescribed the FA use were equally ascertained. They were also asked about their knowledge of dietary fortification with FA. The socioeconomic class of the respondents was obtained using their occupation, based on the Economic and Social Research Council (ESRC) guidelines and categorised into: Class I - managerial and professional, Class II - intermediate and Class III - working class [9].

 

The responses were computed and data analysed using SPSS version 19 (SPSS Inc, Chicago, IL, USA). Univariate statistical analysis was performed on descriptive variables and results presented as proportions, percentages, medians or means and standard deviations. Responses obtained from continuous variables were categorised for the purpose of bivariate analysis using means (for maternal age), primigravida vs. others (for number of pregnancies to date) and three months cut-off for time of booking for antenatal care. Tests of association between independent variables of preconceptional FA intake/awareness of FA intake for the prevention of birth defects and sociodemographic/obstetric variables were conducted using chi-square statistics. In view of the small number of women who commenced FA during preconception and in order to fit into a predictive model, tests of association were conducted between early exposure to FA (defined in this study as commencement of FA before the end of the first trimester of pregnancy) and sociodemographic/maternal obstetric variables. Variables that were significant at a p-value of 0.2 were then entered sequentially into a multinomial logistic regression model with the reference category being late commencement of FA (i.e. commencing FA at a time outside the first trimester of pregnancy). The p-value for statistical significance was set at 0.05.

 

 

Results

Sociodemographic characteristics

 

A total of 602 mothers participated in the study with 340 (56.5%) recruited from the general hospital and 262 (43.5%) from the tertiary hospital. The mean age of the respondents was 29.3 ± 5.0 years (range of 17 to 42 years). Most of the women (587, 97.5%) were married. The majority (398, 66.1%) were in the working class; the rest were either in the managerial and professional socioeconomic class (86, 14.3%) or in the intermediate class (118, 19.6%). A total of 139 (23.0%) respondents had a university degree, 158 (26.2%) had post secondary/high-school education, 302 (50.2%) had between one and twelve years of formal education while 3 (0.5%) had no formal education.

 

Maternal obstetric characteristics

 

Each of the respondents had between one and six pregnancies; 198 (32.9%) were primigravida. The median number of children for each respondent was 2 (range from 1 to 6). The month of registration of the pregnancy of the index baby for antenatal care (ANC) ranged from the first to the eight month (median of five months); only 155 (25.7%) booked within the first three months of pregnancy.

 

FA intake

 

The majority of respondents (559, 92.9%) took FA at some point or the other during pregnancy. The FA was mostly prescribed by a doctor or a nurse (535, 95.7%). Only 15 (2.5%) respondents took FA during preconception. By the end of the first trimester, 163 (29.2%) women had commenced FA intake, i.e. periconceptional, whereas 396 (70.8%) commenced FA at a later date. There were 43 respondents (7.1%) who did not take the supplement at all. Of the 559 respondents who took FA during pregnancy; 17 (3.0%) knew that it could prevent birth defects in addition to its role as a haematinic, 231 (41.3%) knew that it was taken to boost haematocrit or help in maternal well-being during pregnancy while 311 (55.6%) had no idea why it was prescribed to them. Four respondents (0.7%) knew that foods could be fortified with FA and 451 (74.9%), after being provided information about the possibility of such, would recommend strong advocacy for a campaign to have foods fortified with FA in the country, Nigeria.

 

Periconceptional FA intake vs. sociodemographic and maternal obstetric characteristics

 

The proportion of women in the managerial and professional socioeconomic class who took FA periconception was significantly higher than those of women in the intermediate or working classes (55.8%, 33.6% and 21.4% respectively, p < 0.001). Also, a significantly higher proportion of women who had university education took periconceptional FA compared to those with lower levels of education (53.6% vs. 21.1%, p < 0.001). The proportion of primigravid mothers who took folic acid periconception was higher than that of women with more than one previous pregnancy (41.0% vs. 23.4%, p < 0.001). Furthermore, the proportion of respondents who booked for ANC in the first trimester and took FA periconception was higher than that of respondents who booked outside the first trimester of pregnancy but took FA periconception (88.2.2% vs. 6.9%, p < 0.001). There was no association between periconceptional intake of FA and the age or marital status of respondents (Table 1).

 

Knowledge of the role of FA vs. sociodemographic and maternal obstetric characteristics

 

Of the respondents in the managerial and professional socioeconomic class, 11.6% knew that FA could prevent birth defects compared to 0.9% of those in the intermediate class and 1.7% in the working class (p < 0.001). A total of 15 women out of 138 (10.9%) with a university degree who used FA in pregnancy were aware of its preventive role in the aetiopathogenesis of birth defects compared to 2 of the 421 (0.5%) women with less education (p < 0.001). Again, a higher proportion of respondents who booked for ANC in the first trimester knew that FA could be taken to prevent birth defects than those who registered their pregnancies at a later date (5.9% vs. 2.0%, p = 0.016). There was no association between awareness of the preventive role of FA and; respondent's age, marital status and number of pregnancies (Table 2).

 

Predictors of late exposure to FA in pregnancy

 

The results of the multinomial logistic regression analysis for the determinants of late exposure to FA in pregnancy among this study population showed that: (i) respondents in the working socioeconomic class were more likely to be exposed to FA later than recommended in pregnancy compared to those in higher social classes (OR = 4.24, CI: 1.59, 11.31, p = 0.004), (ii) women without university degrees were more likely than those with university education to commence FA late in pregnancy (OR = 4.58, CI: 3.06, 6.87, p < 0.001), and (iii) those who booked later in pregnancy were also more likely to commence later than others (OR = 104.27, CI: 53.09, 204.76, p < 0.001). Maternal age and the number of previous pregnancies, however, did not significantly predict time of commencement of FA in this study population (Table 3).

 

 

Discussion

This study was conducted on a sample of women from different socioeconomic strata representative of a typical developing country. There was a fairly high proportion in the working class, only 23% had a university degree and 75% booked for antenatal care in the second or third trimester of pregnancy [7]. Among this cohort, there is a low prevalence of use of FA during preconception. Only 2.5% of the respondents used the supplement as recommended - daily ingestion of FA prior to pregnancy and well into the third month of conception [3, 4]. Also, only about the same proportion was aware of the role of periconceptional FA in the prevention of birth defects. This prevailing level of knowledge and practice is extremely low when compared to 37% usage during preconception in the Netherlands [10], 30% - 43% in Australia [11], 31% in Israel [12], and 33% - 44% in the United States [13, 14]. The level of awareness, and, usage are, however, similar to what had been reported from other low resource settings such as 5% awareness of the timing of supplementation in Nepalese women [15]. The relatively low rate of utilization of antenatal care services in African and other developing countries [8] may be partly responsible to this abysmal uptake of a beneficial behaviour. This is further confirmed by the low proportion of women (25%) that had registered for antenatal care services by the end of the first trimester. Furthermore, there is no nationally funded campaign or programme on FA supplementation preconception in the country unlike what obtains for iodine and vitamin A fortification by relevant groups in most developing countries [15].

 

Periconceptional FA intake is more likely to be seen in women in higher socioeconomic classes, those with university degrees and who booked early for antenatal care. Knowledge of the role of FA in prevention of birth defects when taken periconception was equally better in these groups of women. Similar pattern of behaviour has been reported among Dutch women, in a study in which those with higher educational attainments regardless of ethnicity were more likely to use FA periconception [10]. Education and social class would seem to play important roles in both usage and awareness of benefits of periconceptional intake of FA because pregnancy tends more likely to be planned by women in these categories. Unplanned pregnancies, which are more often recorded in women of lower socioeconomic classes, those with lower levels of education and those who booked late for pregnancy care have been associated with poorer use of FA periconception [10, 16, 17]. It is also probable that women in higher socioeconomic classes or with better education have greater access to information. They are thus more empowered, and more likely to practice safer health behaviours. Planning pregnancy is important since women usually become aware of their pregnancy about three weeks after becoming pregnant, when FA supplementation may be too late to prevent neural tube defects [15, 18]. That only 44% of the women interviewed knew that FA has benefits as a haematinic may be an evidence that antenatal care counselling is still inadequate in the country. Coupled with the absence of organised screening services for congenital malformations [19], this portends problems in the attempt to reduce the rising incidence of NTDs in poorer nations. Mandatory fortification of grains and other food sources with FA has been suggested as a way of improving the primary preventive efforts. This has resulted in a significant decline in the incidence of NTDs in countries that have implemented such programmes [20]. Although only four women knew that such a programme can be implemented, 75% of the others after a short counselling were highly supportive of pursuing a strong advocacy campaign in this respect.

 

A major limitation of the present study is that it relied on the recollection ability of the mothers as to the details of their use of FA before or during pregnancy. However, in order to minimise the effects of such recall bias, we excluded women whose children were delivered over 11 months before the interview. Another main limitation of this work is the fact that it is not a community or population survey. It is only a hospital-based study whose outcome may not be easily extrapolated to the general population. However, the study was conducted in a highly cosmopolitan Nigerian urban state capital, and the two health facilities chosen for this study were the main obstetric care centres in the city with the various social strata represented.

 

 

Conclusion

In conclusion, periconceptional FA intake in Nigeria is poor amongst mothers generally and particularly significant among those in the working class, those less educated, multigravid or late ANC attendees. The same groups of women are less likely to know about the role of FA in the prevention of birth defects.

 

 

Competing interests

The authors declare no competing interest.

 

 

Authors’ contributions

TAL: conceptualized the study, wrote the proposal, designed the questionnaire, collected the data, did statistical analysis and wrote parts of the manuscript; AOA: assisted in drafting the proposal, designed parts of the questionnaire, did data analysis and wrote parts of the manuscript. All authors have read and agreed to the final version of this manuscript.

 

 

Tables

Table 1: association between periconceptional folic acid intake and sociodemographic/maternal obstetric characteristics of the participants

Table 2: relationship between awareness of folic acid for the prevention of birth defects and sociodemographic/maternal obstetric characteristics of the participants

Table 3: logistic regression analysis of relationship between late exposure to folic acid and sociodemographic/maternal obstetric variables

 

 

References

  1. Cherian A, Seena S, Bullock RK, Antony AC. Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet. 2005; 366(9489):930-93. PubMed | Google Scholar

  2. Ren A, Zhang L, Li Z, Hao L, Tian Y. Awareness and use of folic acid, and blood folate concentrations among pregnant women in northern China--an area with a high prevalence of neural tube defects. Reprod Toxicol. 2006; 22(3):431-436. PubMed | Google Scholar

  3. Medical Research Council. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. The Lancet. 1991; 338(8760):131-137. PubMed | Google Scholar

  4. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992; 327(26):1832-1835. PubMed | Google Scholar

  5. Eghwrudjakpor PO, Amadi CE, Amusan EO. Evaluation of the level of awareness of the role of folic acid in the prevention of neural tube defects amongst women of reproductive age in a tertiary health institution. Niger J Med. 2011; 20(2):207-212. PubMed | Google Scholar

  6. McDonald SD, Ferguson S, Tam L, Lougheed J, Walker MC. The prevention of congenital anomalies with periconceptional folic acid supplementation. J Obstet Gynaecol Can. 2003; 25(2):115-121. PubMed | Google Scholar

  7. Adeleye AO, Dairo MD, Olowookere KG. Central nervous system congenital malformations in a developing country: issues and challenges against their prevention. Childs Nerv Syst. 2010; 26(7):919-924. PubMed | Google Scholar

  8. Rose D, O'Reilly K, Martin J. The ESRC review of government social classifications. POPULATION TRENDS-LONDON. 1997:49-56. PubMed | Google Scholar

  9. Timmermans S, Jaddoe VW, Mackenbach JP, Hofman A, Steegers-Theunissen RP, Steegers EA. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in The Netherlands: the Generation R study. Prev Med. 2008; 47(4):427-432. PubMed | Google Scholar

  10. Conlin ML, MacLennan AH, Broadbent JL. Inadequate compliance with periconceptional folic acid supplementation in South Australia. Aust N Z J Obstet Gynaecol. 2006; 46(6):528-533. PubMed | Google Scholar

  11. Amitai Y, Fisher N, Haringman M, Meiraz H, Baram N, Leventhal A. Increased awareness, knowledge and utilization of preconceptional folic acid in Israel following a national campaign. Prev Med. 2004; 39(4):731-737. PubMed | Google Scholar

  12. Canfield MA, Przybyla SM, Case AP, Ramadhani T, Suarez L, Dyer J. Folic acid awareness and supplementation among Texas women of childbearing age. Prev Med. 2006; 43(1):27-30. PubMed | Google Scholar

  13. Goldberg BB, Alvarado S, Chavez C, Chen BH, Dick LM, Felix RJ, et al. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service. Birth Defects Res A Clin Mol Teratol. 2006; 76(3):193-199. PubMed | Google Scholar

  14. Paudel P, Wing K, Silpakar SK. Awareness of periconceptional folic acid supplementation among Nepalese women of childbearing age: a cross-sectional study. Prev Med. 2012; 55(5):511-513. PubMed | Google Scholar

  15. Ogundipe O, Hoyo C, Ostbye T, Oneko O, Manongi R, Lie RT, et al. Factors associated with prenatal folic acid and iron supplementation among 21,889 pregnant women in Northern Tanzania: a cross-sectional hospital-based study. BMC Public Health. 2012; 12:481. PubMed | Google Scholar

  16. Li Z, Ren A, Zhang L, Guo Z, Li Z. A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatric and perinatal epidemiology. 2006; 20(1):43-53. PubMed | Google Scholar

  17. Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D, Tremblay C. Pregnancy planning and folic acid supplement use: results from a survey in Quebec. Prev Med. 2002; 35(2):143-149. PubMed | Google Scholar

  18. Sadler TW. Embryology of neural tube development. Am J Med Genet C Semin Med Genet. 2005; 135C(1):2-8. PubMed | Google Scholar

  19. Lawal TA, Fatiregun AA, Yusuf OB. Mothers' Awareness of Anorectal Malformations: A Pointer to Delayed Diagnosis in a Developing Country. Eur J Pediatr Surg. 2013; 23(6):480-485. PubMed | Google Scholar

  20. Botto LD, Lisi A, Bower C, Canfield MA, Dattani N, De Vigan C, et al. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol. 2006; 76(10):693-705. PubMed | Google Scholar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


The Pan African Medical Journal articles are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 27 (May - August 2017)

Article tools

This article authors

On Pubmed
On Google Scholar

Rate this article

Altmetric

Popular articles in Research

PAMJ is a member of the Committee on Publication Ethics

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2017 - Pan African Medical Journal. All rights reserved